S1PR3 agonism and S1P lyase inhibition rescue mice in the severe state of experimental sepsis

Authors: Ziegler, Anke C., Haider, Raphael S., Hoffmann, Carsten, Gräler, Markus H.

Source: In Biomedicine & Pharmacotherapy May 2024 174

Validation of a monoclonal antibody directed against the human sphingosine 1-phosphate receptor type 1

Authors: Thuy, Andreas V., Jeya Paul, Jefri, Weigel, Cynthia, Ziegler, Anke C., Guntinas-Lichius, Orlando, Gräler, Markus H.

Source: In Journal of Immunological Methods March 2021 490

Sphingosine 1-phosphate in sepsis and beyond: Its role in disease tolerance and host defense and the impact of carrier molecules

Authors: Ziegler, Anke C., Müller, Tina, Gräler, Markus H.

Source: In Cellular Signalling February 2021 78

Barrier maintenance by S1P during inflammation and sepsis

Authors: Ziegler, Anke C., Gräler, Markus H.

Source: Tissue barriers. 9(4)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100133581350.0x000001&indx=1&recIds=ETOCvdc_100133581350.0x000001

The Impact of Sphingosine Kinases on Inflammation-Induced Cytokine Release and Vascular Endothelial Barrier Integrity.

Authors: Thuy, Andreas V., Reimann, Christina-Maria, Ziegler, Anke C., Gräler, Markus H.

Source: International Journal of Molecular Sciences; Nov2022, Vol. 23 Issue 21, p12848, 19p

Subject Terms: SPHINGOSINE, VASCULAR endothelial cells, KINASES, INTERFERONS, IMMUNOMODULATORS, CYTOKINES, TYPE I interferons